{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T21:05:23Z","timestamp":1785618323360,"version":"3.56.0"},"reference-count":74,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI13\/01237"],"award-info":[{"award-number":["PI13\/01237"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007801","name":"Fundaci\u00f3n S\u00e9neca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007801","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","rbmojournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reproductive BioMedicine Online"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.rbmo.2019.01.013","type":"journal-article","created":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T21:52:58Z","timestamp":1551217978000},"page":"1018-1026","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Are there differences in basal thrombophilias and C-reactive protein between women with or without PCOS?"],"prefix":"10.1016","volume":"38","author":[{"given":"Mar\u00eda L","family":"S\u00e1nchez-Ferrer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda T","family":"Prieto-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiana","family":"Corbal\u00e1n-Biyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Mendiola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evdochia","family":"Adoamnei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana I","family":"Hern\u00e1ndez-Pe\u00f1alver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Carmona-Barnosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo J","family":"Salido-Fi\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto M","family":"Torres-Cantero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rbmo.2019.01.013_bib0001","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ijwd.2017.01.006","article-title":"Association of ethnicity, Fitzpatrick skin type, and hirsutism: A retrospective cross-sectional study of women with polycystic ovarian syndrome","volume":"3","author":"Afifi","year":"2017","journal-title":"International Journal of Women's Dermatology"},{"key":"10.1016\/j.rbmo.2019.01.013_bib0002","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S0015-0282(97)00486-X","article-title":"The plasminogen activator system in women with polycystic ovary syndrome","volume":"69","author":"Atiomo","year":"1998","journal-title":"Fertility and sterility"},{"key":"10.1016\/j.rbmo.2019.01.013_bib0003","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/S0015-0282(00)01614-9","article-title":"Are women with polycystic ovary syndrome resistant to activated protein C?","volume":"74","author":"Atiomo","year":"2000","journal-title":"Fertility and sterility"},{"key":"10.1016\/j.rbmo.2019.01.013_bib0004","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1046\/j.1365-2265.2000.00946.x","article-title":"Raised plasminogen activator inhibitor-1 (PAI-1) is not an independent risk factor in the polycystic ovary syndrome (PCOS)","volume":"52","author":"Atiomo","year":"2000","journal-title":"Clinical endocrinology"},{"key":"10.1016\/j.rbmo.2019.01.013_bib0005","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1111\/aogs.12706","article-title":"Polycystic ovary syndrome: cardiovascular risk factors according to specific phenotypes","volume":"94","author":"Aziz","year":"2015","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"key":"10.1016\/j.rbmo.2019.01.013_bib0006","doi-asserted-by":"crossref","first-page":"720","DOI":"10.3109\/09513590.2015.1032930","article-title":"Endogenous thrombin potential in polycystic ovary syndrome: the association to body mass index, insulin resistance, and inflammation","volume":"31","author":"Aziz","year":"2015","journal-title":"Gynecological endocrinology\u202f: the official journal of the International Society of Gynecological Endocrinology"},{"key":"10.1016\/j.rbmo.2019.01.013_bib0007","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/AOG.0000000000002698","article-title":"Polycystic Ovary Syndrome","volume":"132","author":"Azziz","year":"2018","journal-title":"Obstetrics and gynecology"},{"key":"10.1016\/j.rbmo.2019.01.013_bib0008","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1210\/jc.2003-032046","article-title":"The Prevalence and Features of the Polycystic Ovary Syndrome in an Unselected Population","volume":"89","author":"Azziz","year":"2004","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.rbmo.2019.01.013_bib0009","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1515\/hmbci-2013-0014","article-title":"The impact of hyperandrogenism in female obesity and cardiometabolic diseases associated with polycystic ovary syndrome","volume":"15","author":"Barber","year":"2013","journal-title":"Hormone Molecular Biology and Clinical Investigation"},{"key":"10.1016\/j.rbmo.2019.01.013_bib0010","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2265.2007.02764.x","article-title":"Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome","author":"Barber","year":"2007","journal-title":"Clinical Endocrinology"},{"key":"10.1016\/j.rbmo.2019.01.013_bib0011","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1093\/humupd\/dmu012","article-title":"Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"20","author":"Barry","year":"2014","journal-title":"Human reproduction update"},{"key":"10.1016\/j.rbmo.2019.01.013_bib0012","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1046\/j.1365-2141.1997.882901.x","article-title":"Activated protein C resistance can be associated with recurrent fetal loss","volume":"97","author":"Brenner","year":"1997","journal-title":"British journal of haematology"},{"key":"10.1016\/j.rbmo.2019.01.013_bib0013","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1055\/s-0035-1564837","article-title":"Comprehensive Assessment of the Hemostatic System in Polycystic Ovarian Syndrome","volume":"42","author":"Burchall","year":"2016","journal-title":"Seminars in thrombosis and hemostasis"},{"key":"10.1016\/j.rbmo.2019.01.013_bib0014","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1210\/jc.2005-1457","article-title":"Relative Prevalence of Different Androgen Excess Disorders in 950 Women Referred because of Clinical Hyperandrogenism","volume":"91","author":"Carmina","year":"2006","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.rbmo.2019.01.013_bib0015","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/282676a0","article-title":"Thrombosis and haemostasis","volume":"282","author":"Colman","year":"1979","journal-title":"Nature"},{"key":"10.1016\/j.rbmo.2019.01.013_bib0016","doi-asserted-by":"crossref","first-page":"P1","DOI":"10.1530\/EJE-14-0253","article-title":"The polycystic ovary syndrome: a position statement from the European Society of Endocrinology","volume":"171","author":"Conway","year":"2014","journal-title":"European Journal of Endocrinology"},{"key":"10.1016\/j.rbmo.2019.01.013_bib0017","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0015-0282(16)56575-3","article-title":"Hemostatic and metabolic variables in women with polycystic ovary syndrome","volume":"61","author":"Dahlgren","year":"1994","journal-title":"Fertility and sterility"},{"key":"10.1016\/j.rbmo.2019.01.013_bib0018","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0181467","article-title":"The prevalence and metabolic characteristics of polycystic ovary syndrome in the Qatari population","volume":"12","author":"Dargham","year":"2017","journal-title":"PLOS ONE"},{"key":"10.1016\/j.rbmo.2019.01.013_bib0019","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.fertnstert.2015.05.013","article-title":"Android fat distribution affects some hemostatic parameters in women with polycystic ovary syndrome compared with healthy control subjects matched for age and body mass index","volume":"104","author":"de Mendon\u00e7a-Louzeiro","year":"2015","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.rbmo.2019.01.013_bib0020","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1016\/j.fertnstert.2013.01.105","article-title":"Faster thrombin generation in women with polycystic ovary syndrome compared with healthy controls matched for age and body mass index","volume":"99","author":"de Mendon\u00e7a-Louzeiro","year":"2013","journal-title":"Fertility and sterility"},{"key":"10.1016\/j.rbmo.2019.01.013_bib0021","first-page":"495","article-title":"PCOS women show significantly higher homocysteine level, independent to glucose and E2 level","volume":"14","author":"Eskandari","year":"2016","journal-title":"International journal of reproductive biomedicine (Yazd, Iran)"},{"key":"10.1016\/j.rbmo.2019.01.013_bib0022","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1210\/jcem-21-11-1440","article-title":"Clinical assessment of body hair growth in women","volume":"21","author":"Ferriman","year":"1961","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.rbmo.2019.01.013_bib0023","doi-asserted-by":"crossref","unstructured":"Franks, S., Gharani, N., McCarthy, M., n.d. Candidate genes in polycystic ovary syndrome. Human reproduction update 7, 405\u201310.","DOI":"10.1093\/humupd\/7.4.405"},{"key":"10.1016\/j.rbmo.2019.01.013_bib0024","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1475-2891-2-6","article-title":"Distribution of Serum Total Homocysteine and Its Association with Diabetes and Cardiovascular Risk Factors of the Insulin Resistance Syndrome in Mexican American Men: The Third National Health and Nutrition Examination Survey","volume":"2","author":"Gillum","year":"2003","journal-title":"Nutrition Journal"},{"key":"10.1016\/j.rbmo.2019.01.013_bib0025","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1530\/EJE-14-1108","article-title":"Morbidity and medicine prescriptions in a nationwide Danish population of patients diagnosed with polycystic ovary syndrome","volume":"172","author":"Glintborg","year":"2015","journal-title":"European journal of endocrinology"},{"key":"10.1016\/j.rbmo.2019.01.013_bib0026","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0026-0495(99)90113-0","article-title":"Metformin-induced resumption of normal menses in 39 of 43 (91%) previously amenorrheic women with the polycystic ovary syndrome","volume":"48","author":"Glueck","year":"1999","journal-title":"Metabolism: clinical and experimental"},{"key":"10.1016\/j.rbmo.2019.01.013_bib0027","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/S0026-0495(99)90250-0","article-title":"Plasminogen activator inhibitor activity: an independent risk factor for the high miscarriage rate during pregnancy in women with polycystic ovary syndrome","volume":"48","author":"Glueck","year":"1999","journal-title":"Metabolism: clinical and experimental"},{"key":"10.1016\/j.rbmo.2019.01.013_bib0028","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1177\/1076029612436673","article-title":"Elevated circulating levels of tissue factor in polycystic ovary syndrome","volume":"19","author":"Gonz\u00e1lez","year":"2013","journal-title":"Clinical and applied thrombosis\/hemostasis\u202f: official journal of the International Academy of Clinical and Applied Thrombosis\/Hemostasis"},{"key":"10.1016\/j.rbmo.2019.01.013_bib0029","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/aji.12002","article-title":"Plasminogen Activator Inhibitor 1 and Methylenetetrahydrofolate Reductase Gene mutations in Iranian Women with Polycystic Ovary Syndrome","volume":"68","author":"Idali","year":"2012","journal-title":"American Journal of Reproductive Immunology"},{"key":"10.1016\/j.rbmo.2019.01.013_bib0030","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1080\/09513590802291824","article-title":"Increased thrombin-activatable fibrinolysis inhibitor antigen levels as a clue for prothrombotic state in polycystic ovary syndrome","volume":"24","author":"Karakurt","year":"2008","journal-title":"Gynecological Endocrinology"},{"key":"10.1016\/j.rbmo.2019.01.013_bib0031","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jcma.2013.01.009","article-title":"Correlation between thrombophilia and recurrent pregnancy loss in patients with polycystic ovary syndrome: A comparative study","volume":"76","author":"Kazerooni","year":"2013","journal-title":"Journal of the Chinese Medical Association"},{"key":"10.1016\/j.rbmo.2019.01.013_bib0032","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00404-008-0884-0","article-title":"High mean platelet volume, low-grade systemic coagulation and fibrinolytic activation are associated with androgen and insulin levels in polycystic ovary syndrome","volume":"280","author":"Kebapcilar","year":"2009","journal-title":"Archives of Gynecology and Obstetrics"},{"key":"10.1016\/j.rbmo.2019.01.013_bib0033","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/j.fertnstert.2016.07.1121","article-title":"Phenotypes and body mass in women with polycystic ovary syndrome identified in referral versus unselected populations: systematic review and meta-analysis","volume":"106","author":"Lizneva","year":"2016","journal-title":"Fertility and sterility"},{"key":"10.1016\/j.rbmo.2019.01.013_bib0034","article-title":"Thrombosis and hemorrhage","author":"Loscalzo","year":"2003","journal-title":"Lippincott Williams and Wilkins"},{"key":"10.1016\/j.rbmo.2019.01.013_bib0035","doi-asserted-by":"crossref","first-page":"39","DOI":"10.4236\/ojog.2018.81005","article-title":"The Effects of Plasma Homocysteine in PCOS Women: A Review","volume":"8","author":"Maharjan","year":"2018","journal-title":"Open Journal of Obstetrics and Gynecology"},{"key":"10.1016\/j.rbmo.2019.01.013_bib0036","doi-asserted-by":"crossref","first-page":"3732","DOI":"10.2337\/dc13-0800","article-title":"Glycerol and fatty acids in serum predict the development of hyperglycemia and type 2 diabetes in Finnish men","volume":"36","author":"Mahendran","year":"2013","journal-title":"Diabetes care"},{"key":"10.1016\/j.rbmo.2019.01.013_bib0037","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1055\/s-0029-1242715","article-title":"Polycystic Ovarian Syndrome and the Risk of Cardiovascular Disease and Thrombosis","volume":"35","author":"Mak","year":"2009","journal-title":"Seminars in Thrombosis and Hemostasis"},{"key":"10.1016\/j.rbmo.2019.01.013_bib0038","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1210\/jc.2010-2279","article-title":"Coagulation and Fibrinolytic Disturbances in Women with Polycystic Ovary Syndrome","volume":"96","author":"Manner\u00e5s-Holm","year":"2011","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.rbmo.2019.01.013_bib0039","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.rbmo.2019.01.013_bib0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0157389","article-title":"Association between High Serum Homocysteine Levels and Biochemical Characteristics in Women with Polycystic Ovarian Syndrome: A Systematic Review and Meta-Analysis","volume":"11","author":"Meng","year":"2016","journal-title":"PLOS ONE"},{"key":"10.1016\/j.rbmo.2019.01.013_bib0041","doi-asserted-by":"crossref","first-page":"590","DOI":"10.3109\/09513590.2011.650754","article-title":"Association of thrombophilia and polycystic ovarian syndrome in women with history of recurrent pregnancy loss","volume":"28","author":"Moini","year":"2012","journal-title":"Gynecological Endocrinology"},{"key":"10.1016\/j.rbmo.2019.01.013_bib0042","unstructured":"NATIONAL INSTITUTES OF HEALTH. Evidence-based Methodology Workshop on Polycystic Ovary Syndrome. December 3\u20135, 2012., 2012. 1\u201314."},{"key":"10.1016\/j.rbmo.2019.01.013_bib0043","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1055\/s-2007-994930","article-title":"Protein C and S deficiency","volume":"25","author":"Nizzi","year":"1999","journal-title":"Seminars in thrombosis and hemostasis"},{"key":"10.1016\/j.rbmo.2019.01.013_bib0044","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1210\/jc.2013-3399","article-title":"Hyperandrogenemia Predicts Metabolic Phenotype in Polycystic Ovary Syndrome: The Utility of Serum Androstenedione","volume":"99","author":"O'Reilly","year":"2014","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.rbmo.2019.01.013_bib0045","doi-asserted-by":"crossref","first-page":"350","DOI":"10.3904\/kjim.2009.24.4.350","article-title":"Serum C-Reactive Protein Levels in Normal-Weight Polycystic Ovary Syndrome","volume":"24","author":"Oh","year":"2009","journal-title":"The Korean Journal of Internal Medicine"},{"key":"10.1016\/j.rbmo.2019.01.013_bib0046","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.thromres.2015.10.022","article-title":"Assessing the intersection of cardiovascular disease, venous thromboembolism, and polycystic ovary syndrome","volume":"136","author":"Okoroh","year":"2015","journal-title":"Thrombosis Research"},{"key":"10.1016\/j.rbmo.2019.01.013_bib0047","doi-asserted-by":"crossref","first-page":"377.e1","DOI":"10.1016\/j.ajog.2012.08.007","article-title":"Is polycystic ovary syndrome another risk factor for venous thromboembolism? United States, 2003\u20132008","volume":"207","author":"Okoroh","year":"2012","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1016\/j.rbmo.2019.01.013_bib0048","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1016\/j.fertnstert.2008.03.039","article-title":"Polycystic ovary syndrome is associated with elevated plasma soluble CD40 ligand, a marker of coronary artery disease","volume":"91","author":"Oktem","year":"2009","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.rbmo.2019.01.013_bib0049","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1080\/09513590802549874","article-title":"Thrombin activatable fibrinolysis inhibitor and other hemostatic parameters in patients with polycystic ovary syndrome","volume":"25","author":"Oral","year":"2009","journal-title":"Gynecological Endocrinology"},{"key":"10.1016\/j.rbmo.2019.01.013_bib0050","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1111\/j.1538-7836.2009.03555.x","article-title":"Update of the guidelines for lupus anticoagulant detection","volume":"7","author":"Pengo","year":"2009","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"10.1016\/j.rbmo.2019.01.013_bib0051","article-title":"Inflammation and coagulation","author":"Pet\u00e4j\u00e4","year":"2011","journal-title":"An overview."},{"key":"10.1016\/j.rbmo.2019.01.013_bib0052","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.fertnstert.2016.12.017","article-title":"Normo- and hyperandrogenic women with polycystic ovary syndrome exhibit an adverse metabolic profile through life","volume":"107","author":"Pinola","year":"2017","journal-title":"Fertility and sterility"},{"key":"10.1016\/j.rbmo.2019.01.013_bib0053","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S0140-6736(98)10266-0","article-title":"Venous thrombosis: a multicausal disease","volume":"353","author":"Rosendaal","year":"1999","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.rbmo.2019.01.013_bib0054","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","year":"2004","journal-title":"Human reproduction (Oxford, England)"},{"key":"10.1016\/j.rbmo.2019.01.013_bib0055","first-page":"168","article-title":"Evaluation of homocysteine levels in patients with polycystic ovarian syndrome","volume":"4","author":"Salehpour","year":"2011","journal-title":"International journal of fertility and sterility"},{"key":"10.1016\/j.rbmo.2019.01.013_bib0056","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1093\/humrep\/dex274","article-title":"Presence of polycystic ovary syndrome is associated with longer anogenital distance in adult Mediterranean women","volume":"32","author":"S\u00e1nchez-Ferrer","year":"2017","journal-title":"Human Reproduction"},{"key":"10.1016\/j.rbmo.2019.01.013_bib0057","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1055\/s-2000-8471","article-title":"Biological and Environmental Determinants of Plasma Homocysteine","volume":"26","author":"Schneede","year":"2000","journal-title":"Seminars in Thrombosis and Hemostasis Volume"},{"key":"10.1016\/j.rbmo.2019.01.013_bib0058","series-title":"Clinical gynecologic endocrinology and infertility","author":"Speroff","year":"2005"},{"key":"10.1016\/j.rbmo.2019.01.013_bib0059","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.2337\/db10-1655","article-title":"Effects of 34 Risk Loci for Type 2 Diabetes or Hyperglycemia on Lipoprotein Subclasses and Their Composition in 6,580 Nondiabetic Finnish Men","volume":"60","author":"Stancakova","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.rbmo.2019.01.013_bib0060","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.fertnstert.2013.11.027","article-title":"Hyperandrogenemia is implicated in both the metabolic and reproductive morbidities of polycystic ovary syndrome","volume":"101","author":"Sung","year":"2014","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.rbmo.2019.01.013_bib0061","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1056\/NEJM199503093321003","article-title":"Hemostatic Factors and the Risk of Myocardial Infarction or Sudden Death in Patients with Angina Pectoris","volume":"332","author":"Thompson","year":"1995","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.rbmo.2019.01.013_bib0062","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1093\/humrep\/17.2.314","article-title":"Polycystic ovarian syndrome and thrombophilia","volume":"17","author":"Tsanadis","year":"2002","journal-title":"Human reproduction (Oxford, England)"},{"key":"10.1016\/j.rbmo.2019.01.013_bib0063","doi-asserted-by":"crossref","first-page":"8573","DOI":"10.1073\/pnas.96.15.8573","article-title":"Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin","volume":"96","author":"Urbanek","year":"1999","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.rbmo.2019.01.013_bib0064","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0021-9150(02)00280-0","article-title":"Differential hs-CRP reduction in patients with familial hypercholesterolemia treated with aggressive or conventional statin therapy","volume":"165","author":"van Wissen","year":"2002","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.rbmo.2019.01.013_bib0065","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1515\/CCLM.2003.035","article-title":"Plasma Thiols and Androgen Levels in Polycystic Ovary Syndrome","volume":"41","author":"Vrb\u00edkov\u00e1","year":"2003","journal-title":"Clinical Chemistry and Laboratory Medicine"},{"key":"10.1016\/j.rbmo.2019.01.013_bib0066","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/cen.12086","article-title":"Sex hormone binding globulin and insulin resistance","volume":"78","author":"Wallace","year":"2013","journal-title":"Clinical Endocrinology"},{"key":"10.1016\/j.rbmo.2019.01.013_bib0067","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/ije\/dyv093","article-title":"Sex hormone-binding globulin associations with circulating lipids and metabolites and the risk for type 2 diabetes: observational and causal effect estimates","volume":"44","author":"Wang","year":"2015","journal-title":"International Journal of Epidemiology"},{"key":"10.1016\/j.rbmo.2019.01.013_bib0068","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.atherosclerosis.2004.12.031","article-title":"The metabolic syndrome and insulin resistance: relationship to haemostatic and inflammatory markers in older non-diabetic men","volume":"181","author":"Wannamethee","year":"2005","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.rbmo.2019.01.013_bib0069","doi-asserted-by":"crossref","first-page":"4842","DOI":"10.1210\/jc.2006-1327","article-title":"Characterizing Discrete Subsets of Polycystic Ovary Syndrome as Defined by the Rotterdam Criteria: The Impact of Weight on Phenotype and Metabolic Features","volume":"91","author":"Welt","year":"2006","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.rbmo.2019.01.013_bib0070","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.2337\/db11-1355","article-title":"Metabolic signatures of insulin resistance in 7,098 young adults","volume":"61","author":"W\u00fcrtz","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.rbmo.2019.01.013_bib0071","doi-asserted-by":"crossref","first-page":"648","DOI":"10.2337\/dc12-0895","article-title":"Branched-chain and aromatic amino acids are predictors of insulin resistance in young adults","volume":"36","author":"W\u00fcrtz","year":"2013","journal-title":"Diabetes care"},{"key":"10.1016\/j.rbmo.2019.01.013_bib0072","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001765","article-title":"Metabolic signatures of adiposity in young adults: Mendelian randomization analysis and effects of weight change","volume":"11","author":"W\u00fcrtz","year":"2014","journal-title":"PLoS medicine"},{"key":"10.1016\/j.rbmo.2019.01.013_bib0073","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1210\/jcem.87.8.8716","article-title":"Global Fibrinolytic Capacity Is Decreased in Polycystic Ovary Syndrome, Suggesting a Prothrombotic State","volume":"87","author":"Yildiz","year":"2002","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.rbmo.2019.01.013_bib0074","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1055\/s-0037-1603096","article-title":"Polycystic Ovarian Syndrome: Long-Term Health Consequences","volume":"35","author":"Zore","year":"2017","journal-title":"Seminars in Reproductive Medicine"}],"container-title":["Reproductive BioMedicine Online"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472648319301038?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472648319301038?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:15:50Z","timestamp":1761466550000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1472648319301038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":74,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S1472648319301038"],"URL":"https:\/\/doi.org\/10.1016\/j.rbmo.2019.01.013","relation":{},"ISSN":["1472-6483"],"issn-type":[{"value":"1472-6483","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Are there differences in basal thrombophilias and C-reactive protein between women with or without PCOS?","name":"articletitle","label":"Article Title"},{"value":"Reproductive BioMedicine Online","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rbmo.2019.01.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}